FdaApplication
NDA 017105
Identifiers
- fda_app_no: NDA017105
Properties
| Property | Value |
|---|---|
| applicant_name | AJENAT PHARMACEUTICALS LLC |
| application_type | NDA |
Products (8)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| TRANXENE | CLORAZEPATE DIPOTASSIUM | 3.75MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;ORAL |
| TRANXENE | CLORAZEPATE DIPOTASSIUM | 7.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE;ORAL |
| TRANXENE | CLORAZEPATE DIPOTASSIUM | 15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;ORAL |
| TRANXENE | CLORAZEPATE DIPOTASSIUM | 3.75MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE;ORAL |
| TRANXENE | CLORAZEPATE DIPOTASSIUM | 7.5MG | TABLET;ORAL |
| TRANXENE | CLORAZEPATE DIPOTASSIUM | 15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE;ORAL |
| TRANXENE SD | CLORAZEPATE DIPOTASSIUM | 11.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;ORAL |
| TRANXENE SD | CLORAZEPATE DIPOTASSIUM | 22.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;ORAL |
8 products